High-Intensity Interval Nordic Walking for Coronary Artery Disease
(HIIT-NoW Trial)
Trial Summary
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Research shows that Nordic walking, when combined with standard cardiac rehabilitation, improves physical activity levels, aerobic efficiency, and quality of life in patients with coronary artery disease. It also positively affects certain risk factors for heart disease, making it a more effective therapy than standard cardiac rehabilitation alone.
12345High-Intensity Interval Training (HIIT), which includes High-Intensity Interval Nordic Walking, has shown a low rate of major adverse cardiovascular events in patients with coronary artery disease when used in cardiac rehabilitation settings, with only one major event occurring per 17,083 training sessions.
12456High-intensity interval Nordic walking is unique because it combines the benefits of high-intensity interval training (HIIT) with the full-body engagement of Nordic walking, which uses poles to work more muscle groups. This approach not only improves cardiovascular health but also enhances functional capacity and quality of life, making it a novel option compared to traditional exercise therapies.
12357Eligibility Criteria
This trial is for patients at least 40 years old with coronary artery disease who have had a stent inserted or heart bypass surgery. They must be willing to attend exercise sessions on-site, able to perform an exercise test measuring heart and lung function, and not currently in cardiac rehab.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo high-intensity interval Nordic walking training or standard cardiovascular rehabilitation
Follow-up
Participants are monitored for safety and effectiveness after treatment